Publisher
Springer International Publishing
Reference180 articles.
1. Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, Group ES (2012) Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med 367:716–724
2. Aguilar M, Hart R (2005) Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 4:CD001925
3. Alberio L (2016) Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment of choice. Hamostaseologie 36:241–260
4. Alimam S, Harrison CN (2017) Thrombocytosis and essential thrombocytemia. In: Gresele P et al (eds) Platelets in thrombotic and non-thrombotic disorders: pathophysiology, pharmacology and therapeutics. Springer, Cham, pp 873–886
5. Alvarez-Larrán A, Cervantes F, Pereira A, Arellano-Rodrigo E, Perez-Andreu V, Hernandez-Boluda JC, Ayats R, Salvador C, Muntanola A, Bellosillo B, Vicente V, Hernandez-Nieto L, Burgaleta C, Xicoy B, Besses C (2010) Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood 116:1205–1210